A REVIEW OF CURRENT STEREOTACTIC ABLATIVE RADIOTHERAPY CLINICAL TRIALS FOR OLIGOMETASTATIC CANCERS

被引：0
|
作者：
Arifin, Andrew [1 ]
Al-Shafa, Faiez [1 ]
Rodrigues, George B. [1 ]
Palma, David A. [1 ]
Louie, Alexander V. [2 ]
机构：
[1] Western Univ, London, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
    Morales-Orue, Ignacio
    Zafra-Martin, Juan
    Garcia, Laura
    Chicas-Sett, Rodolfo
    Castilla-Martinez, Juan
    Auxiliadora Cabezon, Maria
    Burgos, Javier
    Lloret, Marta
    Lara, Pedro C.
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S197 - S206
  • [22] Stereotactic Ablative Radiotherapy for oligometastatic soft tissue sarcoma patients
    Greto, D.
    Loi, M.
    Pezzulla, D.
    Lo Russo, M.
    Teriaca, M. A.
    Maragna, V.
    Lucidi, S.
    Campanacci, D. A.
    Beltrami, G.
    Scoccianti, G.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S866 - S866
  • [23] Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer
    Niazi, Tamim
    Elakshar, Sara
    Stroian, Gabriela
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 351 - 358
  • [24] Stereotactic Ablative Radiotherapy For Oligometastatic Patients With Isolated/Limited Lymphnodes
    Fiorentino, A.
    Mazzola, R.
    Fersino, S.
    Ricchetti, F.
    Giaj-Levra, N.
    Gregucci, F.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S451 - S451
  • [25] Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy
    Benson, K.
    Sandhu, N.
    Zhang, C.
    Ko, R. B.
    Toesca, D. A. S.
    Von Eyben, R.
    Diehn, M.
    Bush, K.
    Maxim, P. G.
    Gensheimer, M. F.
    Soltys, S. G.
    Loo, B. W., Jr.
    Pollom, E.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E161 - E162
  • [26] ORGAN AT RISK DOSE CONSTRAINTS IN STEREOTACTIC ABLATIVE RADIOTHERAPY: A SYSTEMATIC REVIEW OF ACTIVE CLINICAL TRIALS
    Gerhard, Serenna G.
    Palma, David A.
    Arifin, Andrew J.
    Louie, Alexander V.
    Li, George J.
    Al-Shafa, Faiez
    Cheung, Patrick
    Rodrigues, George
    Bassim, Carol
    Corkum, Mark T.
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S64 - S65
  • [27] Organ at Risk Dose Constraints in Stereotactic Ablative Radiotherapy: A Systematic Review of Active Clinical Trials
    Gerhard, S. G.
    Palma, D. A.
    Arifin, A. J.
    Louie, A. V.
    Li, G.
    Al-Shafa, F.
    Cheung, P.
    Rodrigues, G.
    Bassim, C.
    Corkum, M. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E477 - E477
  • [28] TWO SEQUENTIAL PILOT STUDIES: STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC BREAST CANCER (BOSTON) AND STEREOTACTIC ABLATIVE RADIOTHERAPY plus PEMBROLIZUMAB FOR OLIGOMETASTATIC BREAST CANCER (BOSTON II)
    David, Steven
    Siva, Shankar
    Bressel, Mathias
    Savas, Peter
    Foroudi, Farshad
    Loi, Sherene
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 167 - 167
  • [29] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [30] Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial
    Senan, S.
    Olson, R.
    Harrow, S.
    Gaede, S.
    Louie, A.
    Haasbeek, C.
    Mulroy, L.
    Lock, M.
    Rodrigues, G.
    Yaremko, B.
    Schellenberg, D.
    Ahmad, B.
    Griffioen, G.
    Senthi, S.
    Liu, M.
    Moore, K.
    Currie, S.
    Bauman, G.
    Warner, A.
    Palma, D.
    ANNALS OF ONCOLOGY, 2018, 29
12345